Enhanced Oral Bioavailability of Efavirenz by Solid Lipid Nanoparticles: <i>In Vitro</i> Drug Release and Pharmacokinetics Studies

<table>Zeta potential distribution (ESLN-3).</table>

BioMed Research International

Figure 4: Enhanced Oral Bioavailability of Efavirenz by Solid Lipid Nanoparticles: <i>In Vitro</i> Drug Release and Pharmacokinetics Studies 